Phone: 800-926-4797 or 941-312-0400
Your membership provides this website - Join Today!

 

HOME

BE INFORMED
  
> About PWS
  
> Get Publications
 
 > About PWSA (USA)
        
Board of Directors
        
Adults with PWS Advisory
       
 Office Staff

MEDICAL
   > Health Concerns
 
 > Medical Alert
  
> Psychiatric
  
> Diet Resources
  
> Growth Hormone

RESEARCH
   >
Research Grants
   >
Funded Research

   > Participants Wanted
   > Research Topics
   > Scientific Advisory Board
   > Clinical Advisory Board

GET INVOLVED
 
  > Spread Awareness
  
> Become member
   >
Registry

SUPPORT
  
 > Newly Diagnosis
   >
Non-Medical

 
 > For Families
  
> For Providers
           
Advisory Board
   >
For Educators

   > State Chapters
   > Links and Resources

MEDIA

GIVE

CONTACT US

 

Long-Term Growth Hormone Therapy Changes the Natural History of Body

Composition and Motor Function in Children with Prader-Willi Syndrome

Aaron L. Carrel, Susan E. Myers, Barbara Y. Whitman, Jens Eickhoff and David B. Allen, Department of Pediatrics, University of Wisconsin American Family Children’s Hospital, Madison, Wisconsin; Department of Pediatrics, Cardinal Glennon Children’s Medical Center, St. Louis, Missouri; and Colorado State University, Ft. Collins, Colorado

To assess the impact of hGH therapy begun early in life on the natural history of PWS, comparisons were made of height, body composition, and strength in similar-age children with PWS who had never been treated with hGH with those with PWS treated with hGH for 6 years.

Forty-eight children with PWS were studied: 21 subjects aged 6–9 years who had been treated with hGH for 6 years beginning at 4–32 months were compared with 27 children aged 5-9 years prior to treatment with hGH. Percent body fat, lean body mass, carbohydrate/lipid metabolism, and motor strength were compared.

Conclusions: hGH treatment in children with PWS, begun prior to 2 years of age, improves body composition, motor function, height, and lipid profiles. The magnitude of these effects suggests that long-term hGH therapy favorably alters the natural history of PWS to an extent that exceeds risks and justifies consideration for initiation during infancy.

[Note: For more detailed information, see The Journal of Clinical Endocrinology & Metabolism Vol. 95, No. 3 1131-1136, 2010]

 edited: 02/09/2012

Return to Home page

PWSA(USA) Disclaimer 

Membership
Payments

PWSA (USA)
Privacy Policy

PWSA (USA) Link Policy

Email PWSA(USA)

 Email Webmaster